Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Halozyme Therapeutics Stock (NASDAQ: HALO) stock price, news, charts, stock research, profile.
You can purchase shares of Halozyme Therapeutics (NASDAQ:HALO) through any online brokerage.
Other companies in Halozyme Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Exact Sciences (NASDAQ:EXAS) and Sarepta Therapeutics (NASDAQ:SRPT).
Halozyme Therapeutics has a consensus price target of $57.14.
The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $56.9 last updated October 31, 2024 at 6:16 PM EDT.
There are no upcoming dividends for Halozyme Therapeutics.
Halozyme Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Halozyme Therapeutics.
Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.